David Campbell
2022
In 2022, David Campbell earned a total compensation of $6M as President and Chief Executive Officer at Janux Therapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $302,500 |
|---|---|
| Option Awards | $5,149,378 |
| Salary | $550,000 |
| Total | $6,001,878 |
Campbell received $5.1M in option awards, accounting for 86% of the total pay in 2022.
Campbell also received $302.5K in non-equity incentive plan and $550K in salary.
Rankings
In 2022, David Campbell's compensation ranked 510th out of 5,760 executives tracked by ExecPay. In other words, Campbell earned more than 91.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 510 out of 5,760 | 91st |
Division Manufacturing | 211 out of 3,136 | 93rd |
Major group Chemicals And Allied Products | 62 out of 1,422 | 96th |
Industry group Drugs | 50 out of 1,323 | 96th |
Industry Pharmaceutical Preparations | 36 out of 969 | 96th |
Source: SEC filing on April 28, 2023.
Campbell's colleagues
We found two more compensation records of executives who worked with David Campbell at Janux Therapeutics in 2022.